...
首页> 外文期刊>Pancreatology: official journal of the International Association of Pancreatology (IAP) ... [et al.] >Cyst fluid SPINK1 may help to differentiate benign and potentially malignant cystic pancreatic lesions
【24h】

Cyst fluid SPINK1 may help to differentiate benign and potentially malignant cystic pancreatic lesions

机译:囊液SPINK1可能有助于区分良性和潜在恶性囊性胰腺病变

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective: Differential diagnosis between benign and potentially malignant cystic pancreatic lesions may be difficult. Previously we have compared cyst fluid serine protease inhibitor Kazal type I (SPINK1) with some traditionally used tumour markers (amylase, CEA, Ca19-9) and found that it may be a new promising maker in the differential diagnosis of cystic pancreatic lesions. In the present study, we focused on cyst fluid SPINK1 levels in benign and potentially malignant cystic pancreatic lesions. Design: Sixty-one patients operated on for cystic pancreatic lesion in Tampere University Hospital, Finland and in Verona University Hospital, Italy, were included. Cyst fluid was aspirated during surgery, stored at -70 -C, and analysed with immunofluorometric assay for SPINK1. The final diagnosis was acute pancreatitis with fluid collection (Acute FC) in 4 patients, chronic pseudocyst (PS) in 17 patients, serous cystadenoma (SCA) in 7 patients, mucinous cystadenoma (MCA) in 21 patients and intraductal papillarymucinous neoplasm (IPMN) in 12 patients (9 main/mixed duct type and 3 branch duct type). Results: The acute FC patients had high SPINK1 levels. Among chronic cysts, SPINK1 levels were significantly higher in patients with potentially malignant cysts (main/mixed duct IPMN and MCA) than with benign cysts (side branch IPMN and SCA), (median and range, [480 (13e3602) vs. 18 (0.1e278) mg/L]; p< 0.0001). In the subcohort of 24 patients with <3 cm chronic cyst, cyst fluid SPINK 1 levels were significantly lower in SCA or side branch IPMN (3 [2e116] mg/L) than in main duct IPMN or MCA (638 [66 e3602] mg/L; p 0.018). The best sensitivity and specificity to differentiate any size MCA or main/mixed type IPMN from SCA or side branch IPMN were 85% and 84% (AUC 0.94; cut-off value 118 mg/L). The best sensitivity and specificity to differentiate <3 cm MCA or main duct IPMN from SCA or side branch IPMN were 93% and 89% (AUC 0.98; cut-off value 146 mg/L). Conclusions: Cyst fluid SPINK1 may be a possible marker in the differential diagnosis of benign and potentially malignant cystic pancreatic lesions.
机译:目的:鉴别良性和潜在恶性囊性胰腺病变可能很困难。以前,我们将囊肿液丝氨酸蛋白酶抑制剂I Kazal I(SPINK1)与一些传统使用的肿瘤标志物(淀粉酶,CEA,Ca19-9)进行了比较,发现它可能是鉴别胰腺囊性胰腺病变的新方法。在本研究中,我们集中于良性和潜在恶性囊性胰腺病变中的囊液SPINK1水平。设计:包括在芬兰坦佩雷大学医院和意大利维罗纳大学医院接受手术治疗的囊性胰腺病变的61例患者。在手术过程中抽吸囊肿液,将其储存在-70 -C下,并用免疫荧光法分析SPINK1。最终诊断为急性胰腺炎,伴有液体收集(急性FC)4例,慢性假性囊肿(PS)17例,浆液性囊腺瘤(SCA)7例,粘液性囊腺瘤(MCA)21例,导管内乳头状黏液性肿瘤(IPMN) 12例(9个主/混合导管型和3个分支导管型)。结果:急性FC患者的SPINK1水平较高。在慢性囊肿中,潜在恶性囊肿(主/混合管IPMN和MCA)患者的SPINK1水平显着高于良性囊肿(侧支IPMN和SCA),(中位数和范围,[480(13e3602)与18( 0.1e278)mg / L]; p <0.0001)。在24例<3 cm慢性囊肿患者的亚队列中,SCA或侧支IPMN的囊液SPINK 1水平(3 [2e116] mg / L)显着低于主导管IPMN或MCA(638 [66 e3602] mg / L; p = 0.018)。区分任何大小的MCA或主要/混合型IPMN与SCA或侧支IPMN的最佳灵敏度和特异性分别为85%和84%(AUC 0.94;截断值118 mg / L)。区分<3 cm MCA或主导管IPMN与SCA或侧支IPMN的最佳灵敏度和特异性分别为93%和89%(AUC 0.98;截断值146 mg / L)。结论:囊肿液SPINK1可能是鉴别诊断胰腺良性和潜在恶性囊性病变的可能标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号